Passage Bio Financial Health

Short Term Liabilities: PASG's short term assets ($222.5M) exceed its short term liabilities ($21.6M).

Long Term Liabilities: PASG's short term assets ($222.5M) exceed its long term liabilities ($24.0M).

Debt Level: PASG is debt free.

Reducing Debt: PASG has not had any debt for past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: PASG has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: PASG has sufficient cash runway for 2.2 years if free cash flow continues to reduce at historical rates of 43.7% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.